title: Danaher Third-Quarter Earnings Rise; Pharma R&D Spend Expected to Rebound
source: Yahoo
date: 2025-10-21
url: https://finnhub.io/api/news?id=ddc7b2d368d3608f038c125ea497cade99a93117fd91e094a3335cd1995ffe84
The life sciences and diagnostics company posted sales of $6.05 billion and stands to benefit from an increase in pharmaceutical-research investment as tariff uncertainty eases.
